DexCom (DXCM) Tops Q4 EPS by 37c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
DexCom (DXCM) PT Raised to $175 at Cowen Following 4Q Report
February 22, 2019 6:43 AM ESTCowen analyst Doug Schenkel raised the price target on DexCom (NASDAQ: DXCM) to $175.00 (from $150.00) while maintaining a Outperform rating following the company's 4Q. Revenue of $338MM came in $53MM ahead of original consensus expectations and $7MM higher than pre-announced results. Gross margin of... More
